These success, along with a preceding report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the idea of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-connected disorders. We independently research, overview, and recommend https://yurik406fxb4.aboutyoublog.com/profile